Clinical Investigators Beware: Greater FDA Review

Law360 (February 17, 2010, 2:04 PM EST) -- While it is common knowledge that the U.S. Food and Drug Administration is being more active in its review of prescription drug advertising by drug product manufacturers, it may not be widely known that the FDA is reviewing what clinical investigators are stating about drugs for which they served as an investigator and which are not yet FDA-approved....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!